A detailed history of Engineers Gate Manager LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 42,873 shares of VERA stock, worth $896,474. This represents 0.02% of its overall portfolio holdings.

Number of Shares
42,873
Holding current value
$896,474
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$24.02 - $43.22 $1.03 Million - $1.85 Million
42,873 New
42,873 $1.03 Million
Q2 2024

Aug 14, 2024

BUY
$33.72 - $48.82 $658,349 - $953,161
19,524 New
19,524 $706,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $565M
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.